Publication - Abstract
Jun 03, 2017
Molecular Pharmaceutics
M.A. Obeid, A. Elburi, L.C. Young, A.B. Mullen, R.J. Tate and V.A. Ferro
Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated...
Read More
Publication - Abstract
Jun 20, 2020
Advanced Drug Delivery Reviews
R. Böttger, G. Pauli, P. Chao, N.A.L. Fayez, L. Hohenwarter and S.D. Li
Liver diseases such as hepatitis, cirrhosis, and hepatocellular carcinoma are global health problems accounting for approximately 800 million cases and over 2 million deaths per year worldwide. Major drawbacks of standard pharmacological therapies are the inability to deliver a s...
Read More